We come to work every day with a sustained commitment to helping improve human health and quality of life, especially for patients suffering from cancer. Each one of us at Deciphera is united in our goal of advancing treatments by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many existing cancer therapies. Our diverse pipeline of drug candidates for the treatment of multiple cancer indications include:
Gastrointestinal Stromal Tumors (GIST)
Breast Cancer
Tenosynovial Giant Cell Tumors (TGCT)
For further information on our clinical trials please contact clinicaltrials@deciphera.com or visit clinicaltrials.gov.